The estimated Net Worth of Brian John is at least $5.13 Million dollars as of 5 October 2021. Mr John owns over 51,556 units of Jupiter Wellness stock worth over $4,213,905 and over the last 4 years he sold JUPW stock worth over $697,500. In addition, he makes $223,583 as Chief Investment Officer and CEO & Exec. Director at Jupiter Wellness.
Sign up
Mr John JUPW stock SEC Form 4 insiders trading
Mr has made over 2 trades of the Jupiter Wellness stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 51,556 units of JUPW stock worth $73,210 on 5 October 2021.
The largest trade he's ever made was selling 250,000 units of Jupiter Wellness stock on 26 July 2021 worth over $697,500. On average, Mr trades about 33,506 units every 8 days since 2020. As of 5 October 2021 he still owns at least 2,772,306 units of Jupiter Wellness stock.
You can see the complete history of Mr John stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Brian Scott John biography
Brian Scott John is the Chief Investment Officer, CEO & Exec. Director at Jupiter Wellness.
What is the salary of Mr John?
As the Chief Investment Officer and CEO & Exec. Director of Jupiter Wellness, the total compensation of Mr John at Jupiter Wellness is $223,583. There are no executives at Jupiter Wellness getting paid more.
How old is Mr John?
Mr John is 52, he's been the Chief Investment Officer and CEO & Exec. Director of Jupiter Wellness since . There are 3 older and 1 younger executives at Jupiter Wellness. The oldest executive at Jupiter Wellness, Inc. is Dr. Glynn Wilson Ph.D., 74, who is the Chief Science Officer & Director.
What's Mr John's mailing address?
Brian's mailing address filed with the SEC is C/O JUPITER WELLNESS, INC.,, 1061 E. INDIANTOWN ROAD, SUITE 110, JUPITER,, FL, 33477.
Insiders trading at Jupiter Wellness
Over the last 4 years, insiders at Jupiter Wellness have traded over $1,509,066 worth of Jupiter Wellness stock and bought 1,922,782 units worth $235,784 . The most active insiders traders include John Gulyas, Brian John, and Skender Fani. On average, Jupiter Wellness executives and independent directors trade stock every 77 days with the average trade being worth of $374,478. The most recent stock trade was executed by John Gulyas on 31 August 2023, trading 1,666,666 units of JUPW stock currently worth $2,533,332.
What does Jupiter Wellness do?
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
What does Jupiter Wellness's logo look like?
Complete history of Mr John stock trades at Jupiter Wellness
Jupiter Wellness executives and stock owners
Jupiter Wellness executives and other stock owners filed with the SEC include:
-
Brian Scott John,
Chief Investment Officer, CEO & Exec. Director -
Richard A. Miller,
Chief Compliance Officer, Sec. & Director -
Dr. Glynn Wilson Ph.D.,
Chief Science Officer & Director -
Ryan T. Allison,
Chief Operating Officer -
Douglas O. McKinnon,
Chief Financial Officer -
Glynn Wilson,
CSO, Chairman -
Byron Young,
CSO, Chairman -
Richard A Miller,
CCO -
Brian John,
CEO -
Ryan T Allison,
CSO, Chairman -
Skender Fani,
Director -
Douglas O Mckinnon,
CFO -
Hector W Alila,
Director -
Kaufman Nancy Torres,
Director -
Christopher Melton,
Director -
John Gulyas,
Director